SCHEMBL6040107

SCHEMBL6040107

CC(C)(C)OC(=O)NC(Cc1cc(F)cc(F)c1)C(O)CNC1(c2cc(Br)cs2)CCc2n[nH]cc2C1

nearest known ligand 0.52

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CTSD P07339 20/20 0.52
BACE1 P56817 20/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5165788 0.92 CTSD (0.57) CTSDBACE1
SCHEMBL6040182 0.90 BACE1 (0.49) CTSDBACE1
SCHEMBL5165919 0.86 CTSD (0.72) CTSDBACE1
SCHEMBL6040138 0.86 CTSD (0.72) CTSDBACE1
SCHEMBL5165929 0.86 CTSD (0.72) CTSDBACE1
SCHEMBL5167035 0.84 BACE1 (0.39) CTSDBACE1
SCHEMBL5670393 0.84 CTSD (0.71) CTSDBACE1
SCHEMBL8283284 0.84 CTSD (0.71) CTSDBACE1
SCHEMBL8274587 0.83 BACE1 (0.67) CTSDBACE1
SCHEMBL4262234 0.83 BACE1 (0.67) CTSDBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060128715-A1 Oxime derivative hydroxyethylamine aspartyl-protease inhibitors ELAN PHARMACEUTICALS, INC. 2006-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060128715-A1 Oxime derivative hydroxyethylamine aspartyl-protease inhibitors ASPH, DNPEP, APP CTSD 417/4885BACE1 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.